Qube Research & Technologies Ltd - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 71 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$25,813
-62.2%
9,890
-68.4%
0.00%
Q1 2023$68,254
-86.8%
31,309
-26.9%
0.00%
-100.0%
Q4 2022$515,257
+175.5%
42,831
+48.7%
0.00%
+200.0%
Q3 2022$187,000
-23.0%
28,795
-45.8%
0.00%
-50.0%
Q2 2022$243,000
-50.1%
53,128
-5.7%
0.00%
-50.0%
Q1 2022$487,000
-47.4%
56,348
-13.0%
0.00%
-42.9%
Q4 2021$925,000
+320.5%
64,799
+294.9%
0.01%
+133.3%
Q2 2021$220,000
-4.3%
16,407
-69.8%
0.00%0.0%
Q4 2020$230,000
+16.8%
54,291
-28.0%
0.00%0.0%
Q3 2020$197,000
+245.6%
75,395
+365.7%
0.00%
+200.0%
Q2 2020$57,00016,1910.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders